文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺放疗引起的正常组织积分剂量:高剂量率近距离治疗与现代外照射技术的定量比较

Normal Tissue Integral Dose as a Result of Prostate Radiation Therapy: A Quantitative Comparison Between High-Dose-Rate Brachytherapy and Modern External Beam Radiation Therapy Techniques.
PubMed 文献 · Adv Radiat Oncol · 2022-12-27

研究对10例典型解剖患者生成4种放疗技术计划,比较正常组织积分剂量。高剂量率近距离治疗正常组织积分剂量最低,较容积旋转调强放疗绝对降低91%,较立体定向体部放疗和笔束扫描质子治疗分别降低57%和17%,所有降低均具统计学显著性。

要点

  • 高剂量率近距离治疗正常组织积分剂量最低,较容积旋转调强放疗绝对降低91%。
  • 笔束扫描质子治疗和立体定向体部放疗较容积旋转调强放疗分别绝对降低17%和57%。
  • 近距离治疗较容积旋转调强放疗、立体定向体部放疗和质子治疗均显著降低正常组织受照剂量。

核心结论

  • 高剂量率近距离治疗是相对于容积旋转调强放疗、立体定向体部放疗和笔束扫描质子治疗减少非靶区身体组织剂量的有效技术。

研究设计与样本

  • 为10例典型解剖患者生成4种放疗技术计划:常规容积旋转调强放疗、立体定向体部放疗、笔束扫描质子治疗和高剂量率近距离治疗。
  • 近距离治疗计划放置虚拟针以达到标准剂量学,并按需应用标准计划靶区边界或稳健性边界。
  • 生成「正常组织」结构(整个计算机断层扫描模拟体积减去计划靶区)用于积分剂量计算。

主要发现

  • 正常组织积分剂量在近距离治疗中最低;笔束扫描质子治疗、立体定向体部放疗和近距离治疗较标准容积旋转调强放疗分别绝对降低17%、57%和91%。
  • 接受25%、50%和75%处方剂量的平均非靶组织,近距离治疗较容积旋转调强放疗分别减少85%、76%和83%。
  • 接受25%、50%和75%处方剂量的平均非靶组织,近距离治疗较立体定向体部放疗分别减少79%、64%和74%。
  • 接受25%、50%和75%处方剂量的平均非靶组织,近距离治疗较质子治疗分别减少73%、60%和81%。
  • 使用近距离治疗观察到的所有降低均具有统计学显著性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Quantification of integral radiation dose delivered during treatment for prostate cancer is lacking. We performed a comparative quantification of dose to nontarget body tissues delivered via 4 common radiation techniques: conventional volumetric modulated arc therapy, stereotactic body radiation therapy, pencil-beam scanning proton therapy, and high-dose-rate brachytherapy. METHODS AND MATERIALS: Plans for each radiation technique were generated for 10 patients with typical anatomy. For brachytherapy plans, virtual needles were placed to achieve standard dosimetry. Standard planning target volume margins or robustness margins were applied as appropriate. A "normal tissue" structure (entire computed tomography simulation volume minus planning target volume) was generated for integral dose computation. Dose-volume histogram parameters for targets and normal structures were tabulated. Normal tissue integral dose was calculated by multiplying normal tissue volume by mean dose. RESULTS: Normal tissue integral dose was lowest for brachytherapy. Pencil-beam scanning protons, stereotactic body radiation therapy, and brachytherapy resulted in 17%, 57%, and 91% absolute reductions compared with standard volumetric modulated arc therapy, respectively. Mean nontarget tissues receiving 25%, 50%, and 75% of the prescription dose were reduced by 85%, 76%, and 83% for brachytherapy relative to volumetric modulated arc therapy, by 79%, 64%, and 74% relative to stereotactic body radiation therapy, and 73%, 60%, and 81% relative to proton therapy. All reductions observed using brachytherapy were statistically significant. CONCLUSIONS: High-dose-rate brachytherapy is an effective technique for reducing dose to nontarget body tissues relative to volumetric modulated arc therapy, stereotactic body radiation therapy, and pencil-beam scanning proton therapy.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Grzywacz VP, Arden JD, Mankuzhy NP, et al. Normal Tissue Integral Dose as a Result of Prostate Radiation Therapy: A Quantitative Comparison Between High-Dose-Rate Brachytherapy and Modern External Beam Radiation Therapy Techniques. Adv Radiat Oncol. 2022. PMID: 36896212. doi:10.1016/j.adro.2022.101160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。